Chicago Rivet & Machine (CVR) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
29 Sep, 2025Executive summary
Net sales for Q1 2025 were $7.25M, down 7.7% year-over-year, with both fastener and assembly equipment segments experiencing declines.
Gross margins improved significantly in both segments due to revised pricing, cost reductions, and operational consolidation.
Net income for Q1 2025 was $401K ($0.42/share), reversing a net loss of $698K ($0.72/share) in Q1 2024.
A one-time gain of $340K from the sale of the Albia facility contributed to higher other income.
Financial highlights
Q1 2025 net sales: $7.25M (vs. $7.85M in Q1 2024); gross profit: $1.66M (vs. $745K); operating income: $70K (vs. loss of $903K).
Net income: $401K in Q1 2025 vs. net loss of $698K in Q1 2024.
Cash and cash equivalents at March 31, 2025: $766K (down from $1.92M at year-end 2024).
Working capital increased to $10.73M from $10.37M at year-end.
Outlook and guidance
Order volume improved sequentially from Q4 2024 but remains below Q1 2024 levels.
Management expects continued uncertainty due to tariffs, market volatility, and automotive sector weakness.
Strategic focus on cost control, efficiency, and new sales initiatives to drive future growth.
Latest events from Chicago Rivet & Machine
- Net loss widened and liquidity concerns persist, raising substantial doubt about going concern.CVR
Q2 2026 - Sales and margins declined sharply in Q1 2026, raising substantial going concern risks.CVR
Q1 2026 - Annual meeting to elect directors and ratify auditor, with strong governance and risk oversight.CVR
Proxy filing - Substantial doubt remains about going concern status despite improved margins and narrowed losses.CVR
Q4 2025 - Shareholders will vote on director elections, executive pay, auditor ratification, and governance matters.CVR
Proxy Filing - Returned to profitability in Q3 2025, but going concern risks persist amid industry challenges.CVR
Q3 2025 - Q2 2024 returned to profit on improved margins, despite flat sales and ongoing risk from a product issue.CVR
Q2 2024 - Sales fell 12.3% YoY in Q3 2024, with improved margins but a net loss of $1.45M.CVR
Q3 2024 - Significant 2024 losses, liquidity risks, and operational restructuring amid industry headwinds.CVR
Q4 2024